blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1691811

EP1691811 - COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.05.2015
Database last updated on 09.04.2026
Most recent event   Tooltip08.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 10.08.2016  [2016/32]
Applicant(s)For all designated states
Sunovion Pharmaceuticals Inc.
84 Waterford Drive
Marlborough, MA 01752-7010 / US
[2014/02]
Former [2006/34]For all designated states
SEPRACOR, INC.
84 waterford Drive
Marlborough, MA 01752-7010 / US
Inventor(s)01 / LALJI, Karim
14 South Meadow Drive
Sudbury, MA 01776 / US
02 / BARBERICH, Timothy, J.
40 Elm Street
Concord, MA 01742 / US
03 / CARON, Judy
5 Westview Terrace
Westwood, MA 02090 / US
04 / WESSEL, Thomas
22 Cliffwood Street
Lenox, MA 01240 / US
 [2014/11]
Former [2006/34]01 / LALJI, Karim
14 South Meadow Drive
Sudbury, MA 01776 / US
02 / BARBERICH, Timothy, J.
40 Elm Street
Concord, MA 01742 / US
03 / CARON, Judy
5 Westview Terrace
Westwood, MA 02090 / US
04 / WESSEL, Thomas
50 Cliffwood Street
Lenox, MA 01240 / US
Representative(s)Cooke, Richard Spencer, et al
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[2014/02]
Former [2008/49]Hutchins, Michael Richard
Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Former [2007/10]Atkinson, Jonathan David Mark, et al
Harrison Goddard Foote Belgrave Hall Belgrave Street
Leeds LS2 8DD / GB
Former [2006/34]Atkinson, Jonathan David Mark
Urquhart-Dykes & Lord LLP Tower North Central Merrion Way
Leeds LS2 8PA / GB
Application number, filing date04813295.508.12.2004
[2006/34]
WO2004US40962
Priority number, dateUS20030529156P11.12.2003         Original published format: US 529156 P
US20040541614P04.02.2004         Original published format: US 541614 P
US20040633213P03.12.2004         Original published format: US 633213 P
[2006/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005060968
Date:07.07.2005
Language:EN
[2005/27]
Type: A1 Application with search report 
No.:EP1691811
Date:23.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 07.07.2005 takes the place of the publication of the European patent application.
[2006/34]
Type: B1 Patent specification 
No.:EP1691811
Date:23.07.2014
Language:EN
[2014/30]
Search report(s)International search report - published on:EP07.07.2005
ClassificationIPC:A61K31/137, A61K31/495, A61K31/724, A61K45/06, A61K31/4985, A61K31/138
[2013/51]
CPC:
A61K31/4985 (EP,US); A61K31/137 (EP,US); A61K31/138 (EP,US);
A61K31/495 (EP,US); A61K31/724 (EP,US); A61K45/06 (EP,US);
A61P25/20 (EP); A61P25/24 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/137, A61K2300/00 (US,EP);
A61K31/138, A61K2300/00 (EP,US);
A61K31/495, A61K2300/00 (US,EP);
A61K31/4985, A61K2300/00 (US,EP);
A61K31/724, A61K2300/00 (EP,US)
(-)
Former IPC [2006/34]A61K31/4985, A61K31/138, A61P25/20, A61P25/24
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/34]
TitleGerman:KOMBINATION AUS EINEM SEDATIVUM UND EINEM NEUROTRANSMITTER-MODULATOR UND VERFAHREN ZUR VERBESSERUNG DER SCHLAFQUALITÄT UND ZUR BEHANDLUNG VON DEPRESSION[2006/34]
English:COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION[2006/34]
French:COMBINAISON D'UN SEDATIF ET D'UN MODULATEUR DES NEUROTRANSMETTEURS, ET METHODES PERMETTANT D'AMELIORER LA QUALITE DU SOMMEIL ET DE TRAITER LA DEPRESSION[2006/34]
Entry into regional phase12.05.2006National basic fee paid 
12.05.2006Designation fee(s) paid 
12.05.2006Examination fee paid 
Examination procedure05.05.2006Amendment by applicant (claims and/or description)
12.05.2006Examination requested  [2006/34]
12.03.2009Despatch of a communication from the examining division (Time limit: M06)
28.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
04.01.2010Reply to a communication from the examining division
16.05.2011Despatch of a communication from the examining division (Time limit: M06)
27.09.2011Reply to a communication from the examining division
24.06.2013Despatch of a communication from the examining division (Time limit: M04)
04.11.2013Reply to a communication from the examining division
19.02.2014Communication of intention to grant the patent
13.06.2014Fee for grant paid
13.06.2014Fee for publishing/printing paid
13.06.2014Receipt of the translation of the claim(s)
Divisional application(s)EP11158892.7  / EP2343073
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.03.2009
Opposition(s)24.04.2015No opposition filed within time limit [2015/27]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
06.01.2010Request for further processing filed
06.01.2010Full payment received (date of receipt of payment)
Request granted
20.01.2010Decision despatched
Fees paidRenewal fee
19.12.2006Renewal fee patent year 03
16.11.2007Renewal fee patent year 04
15.12.2008Renewal fee patent year 05
11.12.2009Renewal fee patent year 06
15.12.2010Renewal fee patent year 07
12.12.2011Renewal fee patent year 08
11.12.2012Renewal fee patent year 09
12.12.2013Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY23.07.2014
EE23.07.2014
LT23.07.2014
MC23.07.2014
RO23.07.2014
SI23.07.2014
SK23.07.2014
TR23.07.2014
BG23.10.2014
IS23.11.2014
[2016/32]
Former [2016/27]CY23.07.2014
EE23.07.2014
LT23.07.2014
MC23.07.2014
RO23.07.2014
SI23.07.2014
SK23.07.2014
BG23.10.2014
IS23.11.2014
Former [2015/50]CY23.07.2014
EE23.07.2014
LT23.07.2014
RO23.07.2014
SI23.07.2014
SK23.07.2014
BG23.10.2014
IS23.11.2014
Former [2015/23]CY23.07.2014
EE23.07.2014
LT23.07.2014
RO23.07.2014
SK23.07.2014
BG23.10.2014
IS23.11.2014
Former [2015/22]CY23.07.2014
LT23.07.2014
RO23.07.2014
BG23.10.2014
IS23.11.2014
Former [2015/12]CY23.07.2014
LT23.07.2014
BG23.10.2014
IS23.11.2014
Former [2015/11]CY23.07.2014
LT23.07.2014
BG23.10.2014
Former [2015/10]LT23.07.2014
BG23.10.2014
Former [2015/08]LT23.07.2014
Cited inInternational search[I]   ASNIS G M ET AL: "Zolpidem for persistent insomnia in SSRI-treated depressed patients.", THE JOURNAL OF CLINICAL PSYCHIATRY. OCT 1999, vol. 60, no. 10, October 1999 (1999-10-01), pages 668 - 676, XP009046236, ISSN: 0160-6689 [I] 1-87,307-326 * table 2 *
 [I]   DOGHRAMJI P P: "Treatment of insomnia with zaleplon, a novel sleep medication", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 2001 UNITED KINGDOM, vol. 55, no. 5, 2001, pages 329 - 334, XP009046237, ISSN: 1368-5031 [I] 1-87,307-326 * page 330, paragraph L *
 [I]   VALUCK R J: "Treatment of depression with citalopram, fluoxetine, paroxetine, sertraline, and venlafaxine in managed care: Part 2 - Patient comorbidities and coprescribed therapies", DRUG BENEFIT TRENDS 2002 UNITED STATES, vol. 14, no. 8, 2002, pages 33 - 40, XP001205671, ISSN: 1080-5826 [I] 1-87,148-222,307-326 * table 3 *
 [I]   DIEPERINK M E ET AL: "Zolpidem for insomnia related to PTSD.", PSYCHIATRIC SERVICES (WASHINGTON, D.C.) MAR 1999, vol. 50, no. 3, March 1999 (1999-03-01), pages 421, XP002324744, ISSN: 1075-2730 [I] 1-87,148-326 * the whole document *
by applicant  BIXLER ET AL., AMER. JOURNAL OF PSYCHIATRY, vol. 136, 1979, pages 1257 - 1262
   LUGARESI ET AL., PSYCHIATRIC ANNALS, vol. 17, 1987, pages 446 - 453
   KARACAN ET AL., SOCIAL SCIENCE AND MEDICINE, vol. 10, 1976, pages 239 - 244
   DIEPERINK M. E ET AL., PSYCHIATRIC SERVICES, vol. 50, no. 3, 1999, pages 421
   ASNIS G. M ET AL., THE JOURNAL OF CLINICAL PSYCHIATRY, vol. 60, no. 10, 1999, pages 668 - 676
   DOGHRAMJI P. P, INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol. 55, no. 5, 2001, pages 329 - 334
   VALUCK R. J, DRUG BENEFIT TRENDS, vol. 14, no. 8, 2002, pages 33 - 40
   ROTH T, INT. J. CLIN. PRACT. SUPPL., 2001, pages 3 - 8
   "Diagnostic and Statistical Manual of Mental Disorders. 4th ed. W", 2000, AMERICAN PSYCHIATRIC PUBLISHING, INC
   "International Classification of Sleep Disorders (ICSD): Diagnostic and Coding Manual", 1990, AMERICAN SLEEP DISORDERS ASSOCIATION
   ROTH T., INT. J. CLIN. PRACT. SUPPL., 2001, pages 3 - 8
   RAJPUT ET AL., AM. FAM. PHYSICIAN, vol. 60, 1999, pages 1431 - 1438
   BENCA RM, J. CLIN. PSYCHIATRY, vol. 62, no. 10, 2001, pages 33 - 38
   ROTH ET AL., SLEEP, vol. 22, no. 2, 1999, pages S3 54 - S358
   BONNET MH, PHYSIOL. BEHAV., vol. 45, 1989, pages 1049 - 1055
   J. HYTTEL, PROG. NEURO-PSYCHOPHARNIACOL. & BIOL. PSYCHIAT., vol. 6, 1982, pages 277 - 295
   A. GRAVEM, ACTA PSYCHIATR. SCAND., vol. 75, 1987, pages 478 - 486
   CHRISTENSEN ET AL.: "reported on the pharmacology of citalopram", EUR. J. PHARMACOL., vol. 41, 1977, pages 153
   DUFOUR ET AL., INT. CLIN. PSYCHOPHARMACOL., vol. 2, 1987, pages 225
   TIMMERMAN ET AL., INT.CLIN. PSYCHOPHARMACOL., pages 239
   "Physicians' Desk Reference, 48th Edition,", 1994, pages: 877 - 880
   ROBERTSON ET AL., J. MED. CHEM., vol. 31, 1988, pages 1412
   NETH. PAT. APPL., vol. 7, no. 503, pages 310
   CLAASSEN ET AL., BRIT. J. PHARMACOL., vol. 60, 1977, pages 505
   WILDE ET AL., J. AFFECTIVE DISORD., vol. 4, 1982, pages 249
   BENFIELD ET AL., DRUGS, vol. 32, 1986, pages 313
   MORET ET AL., NEUROPHARMACOLOGY, vol. 24, 1985, pages 1211 - 1219
   PALMIER ET AL., EUR. J. CLIN. PHARMACOL., vol. 3, 1989, pages 235 - 238
   SPENCER; WILDE, DRUGS, vol. 56, 1998, pages 405 - 427
   MORET; COWORKERS, NEUROPHARMACOLOGY, vol. 24, 1985, pages 1211 - 19
   "Merck Index"
   VIAZZO ET AL., TETRAHEDRON LETT., vol. 37, 1996, pages 4519 - 4522
   DEPREZ ET AL., EUR. J. DRUG METAB. PHARMACOKINET., vol. 23, 1998, pages 166 - 171
   GRARD ET AL., ELECTROPHORESIS, vol. 21, 2000, pages 3028 - 3034
   LASSEN ET AL., EUR. J. PHARMACOL., vol. 47, 1978, pages 351
   HASSAN ET AL., BRIT. J. CLIH. PHARMACOL., vol. 19, 1985, pages 705
   LAURSEN ET AL., ACTA PSYCHIAT. SCAND., vol. 71, 1985, pages 249
   BATTEGAY ET AL., NEUROPSYCHOBIOLOGY, vol. 13, 1985, pages 31
   "Physicians' Desk Reference 48th Edition,", 1994, pages: 2000 - 2003
   G. LEFUR ET AL., LIFE SCI., vol. 23, 1978, pages 1959
   R. ASHKENAZI ET AL., BRIT. J. PHARMACOL., vol. 79, 1983, pages 765 - 915
   J. CHEM. SOC. PERKIN TRANS. I, 1996, pages 1495 - 1498
   GOA; HEEL, DRUGS, vol. 32, 1986, pages 48 - 65
   GOODMAN; GILMAN: "The Pharmacological Basis of Therapeutics, 7th. Edition,", 1985, MACMILLAN PUBLISHING CO., pages: 340 - 351
   BARDONE, M. C. ET AL.: "7th. Int. Congr. Pharm.", July 1978, PERGAMON PRESS
   JULOU, L. ET AL., PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, vol. 23, 1985, pages 653 - 659
   JULOU, L. ET AL., PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, 1985
   HAEFELY, W.: "Psychotropic Agents", 1981, SPRINGER VERLAG, pages: 12 - 262
   IRWIN, S., PSYCHOPHARRMACOLOGIA, vol. 13, 1968, pages 222 - 257
   H. BLUMBERG ET AL., PROC. SOC. EXP. MED., vol. 118, 1965, pages 763 - 766
   E. W. PELIKAN, THE PHARMACOLOGIST, vol. 1, 1959, pages 73
   B E KORBA, ANTIVIRAL RES., vol. 29, 1996, pages 49
   BERGE ET AL.: "Pharmaceutical Salts", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19
   "Applied Animal Nutrition", 1969, W.H. FREEDMAN AND CO.
   "Livestock Feeds and Feeding", 1977, O AND B BOOKS
   DORDUNOO, S. K. ET AL., DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 17, no. 12, 1991, pages 1685 - 1713
   SHEEN, P. C. ET AL., J PHARM SCI, vol. 80, no. 7, 1991, pages 712 - 714
   VAN UDEN ET AL., PLANT CELL TISS. ORG. CULT., vol. 38, 1994, pages 1 - 3,113
   WENZ, AGNEW. CHEM. INT. ED. ENGL., vol. 33, 1994, pages 803 - 822
   "Liposomes: A practical approach", 1990, IRL PRESS, pages: 33 - 104
   "Liposomes from physics to applications", 1993, ELSEVIER SCIENCE PUBLISHERS BV
   "Handbook of Pharmaceutical Excipients", 1986, AMERICAN PHARMACEUTICAL ASSOCIATION
   ARTHUR OSOL,: "Remington's Pharmaceutical Sciences", 1980, pages: 1553 - 1593
   "Handbook of Chemistry and Physics", pages: 1986 - 87
   BR. J. SOC. CLIN. PSYCHOL., vol. 6, 1967, pages 278 - 296
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.